(2-((2-fluoro-4-iodophenyl)amino)phenyl)(4-methylpiperazin-1-yl)methanone

ID: ALA4127200

PubChem CID: 117955916

Max Phase: Preclinical

Molecular Formula: C18H19FIN3O

Molecular Weight: 439.27

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(C(=O)c2ccccc2Nc2ccc(I)cc2F)CC1

Standard InChI:  InChI=1S/C18H19FIN3O/c1-22-8-10-23(11-9-22)18(24)14-4-2-3-5-16(14)21-17-7-6-13(20)12-15(17)19/h2-7,12,21H,8-11H2,1H3

Standard InChI Key:  LLPCMEOKPPPYJT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   11.7755   -8.4138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0610   -8.0013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755   -9.2388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900   -9.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900  -10.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755  -10.8888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0610  -10.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0610   -9.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755  -11.7138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900   -8.0013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900   -7.1763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2045   -6.7638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9189   -7.1763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9189   -8.0013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2045   -8.4138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755   -6.7638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755   -5.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0610   -5.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0610   -4.7013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755   -4.2888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900   -4.7013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4900   -5.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7755   -3.4638    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   10.3466   -5.9388    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  3  8  1  0
  6  9  1  0
  1  3  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 22  2  0
 20 23  1  0
 18 24  1  0
 16 17  1  0
 11 16  1  0
  1 10  1  0
M  END

Associated Targets(Human)

MAP2K2 Tclin Dual specificity mitogen-activated protein kinase kinase; MEK1/2 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K5 Tchem Dual specificity mitogen-activated protein kinase kinase 5 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.27Molecular Weight (Monoisotopic): 439.0557AlogP: 3.56#Rotatable Bonds: 3
Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.85CX LogP: 4.93CX LogD: 4.82
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: -1.95

References

1. Chakrabarty S, Monlish DA, Gupta M, Wright TD, Hoang VT, Fedak M, Chopra I, Flaherty PT, Madura J, Mannepelli S, Burow ME, Cavanaugh JE..  (2018)  Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways.,  28  (13): [PMID:29803729] [10.1016/j.bmcl.2018.05.029]

Source